Warning letters, 483s, Recalls, Import Alerts, Audit observations
Natco Pharma (india) Kothur facility was inspected by USFDA in October 2023. The site (FEI
Panacea Biotec, Baddi facility was inspected by USFDA in Oct 2023- investigators Sandra A Boyd
Nectar Lifesciences was issued an Untitled letter (UL) by USFDA in Sep 23 citing deficiencies
In a company announcement, Biocon informed that it has received a CR (Complete response) letter
The USFDA Warning letter to K. C. Pharmaceuticals issued in August 2023, following inspection at
